
🇸🇬 #Cancer researcher, pharmacist & caregiver | #pharmcoepi & #decisionscience postdoc @YaleMed | Tweets are my own.
New Haven, CT
Joined January 2017
- Tweets195
- Following409
- Followers103
- Likes672
While preparing for this interview, it took a while for me to think carefully about my key motivations to take this #phdjourney and #research path that I have chosen. Once again, I am grateful to have received the #PhF23 award that have unlocked many more opportunities.
After watching his father battle #cancer & experience severe pain w/ no relief from medicines, #PhF23 awardee @dquin_ng of @UCI_SPPS is using real-world data to assess the value of #acupuncture for treating cancer-related #pain.
Watch the full interview: ow.ly/6SiI50PFZAm
Quinton Ng, PhD BScPharm(Hons) retweeted
Abstract submissions are now open for #MASCC27!
Abstract submissions which include a Conference Scholarship application are due by December 16, 2026 at 3:00 PM EST.
All other abstracts are due by January 13, 2027 at 3:00 PM EST
Learn more: mascc.org/annualmeeting2027/…
Quinton Ng, PhD BScPharm(Hons) retweeted
We are pleased to share the autumn 2026 issue of #Breakthroughs is now available! Breakthroughs highlights our continued commitment to putting patients first at @YaleCancer and @SmilowCancer through personalized medicine, innovative research, and advancements in cancer treatment.
➡️medicine.yale.edu/breakthrou…
@YaleMed @YNHH @YaleMedicine
Quinton Ng, PhD BScPharm(Hons) retweeted
Exercise oncology is not just good for patients, it may be a smart investment. A team from Yale completed a cost-effectiveness analysis of the #CHALLENGEtrial + demonstrated the economic viability of reimbursing supervised exercise for patients with #coloncancer in the US.
ascopubs.org/doi/pdf/10.1200…
@SmilowCancer @GeorgeGoshuaMD @JCOOP_ASCO @ammanuelstaye @ManrajSra @SatokoItoMDPhD
Editor's Choice: What does cancer cost #Medicare in older adults?
SEER-Medicare, age 66+ vs matched controls: annual net costs peak at end of life ($121,746) vs initial ($45,063) & continuing ($7,141) care.
Read Now: oxford.ly/4zhG1l2
@theNCI
#Oncology
Quinton Ng, PhD BScPharm(Hons) retweeted
Dr @QasimHussainiMD #ASCOQLTY26 on two RCT on remotedly delivered exercise in specific vulnerable populations. He highlights that it is important to tailor our programs to specific groups & to identify ways to deliver sustainable exercise-therapy, including payment measures.
Quinton Ng, PhD BScPharm(Hons) retweeted
Dr. @QasimHussainiMD giving an amazing discussion of two studies on #ExerciseOncology presented at @ASCO Quality Care Symposium this morning.
asco.org/quality/program
#ASCOQLTY26 @crisbergerot @PauloBergerot
When we incentivize quality care with dollars, we may forget the core values of delivering quality care. Great talk by Dr. Jennifer Griggs! #ASCOQLTY26
9
322
Quinton Ng, PhD BScPharm(Hons) retweeted
Thank you to Dr. Olivier Elemento @ElementoLab
for presenting #GrandRounds on #AI for #PrecisionOncology. He outlined plans to advance #personalizedmedicine by using AI to better understand the biology of each patient’s #cancer. Watch his full talk youtube.com/watch?v=74GV4cfw…
@SmilowCancer @WCMEnglanderIPM @WCMC_CTSC
Quinton Ng, PhD BScPharm(Hons) retweeted
Cost-Effectiveness of Supervised Exercise to Reduce Colon Cancer Progression and Mortality - Quinton Ng
@dquin_ng
oncodaily.com/science/quinto…
Ever wonder if reimbursing #ExerciseOncology can be economically viable in the US? Based on the CHALLENGE trial, I’ll share my answer at #ASCOQLTY26 in Boston (A7, Oct 16). Grateful for the @ConquerCancerFd Merit Award. Come say hi or grab a coffee! asco.org/abstracts-presentat…
10 MET-hours/week (equivalent to 3 hours of brisk walking or 1.5 hours of jogging) improves the 8-year survival rate for colon cancer patients, increasing it from 83.2% to 90.3%. #CancerResearch #CancerSurvivorship #ExerciseOncology
nejm.org/doi/full/10.1056/NE…
6
144
Quinton Ng, PhD BScPharm(Hons) retweeted
How to write a rebuttal letter
Nature Methods, Editorial
nature.com/articles/s41592-0…
Quinton Ng, PhD BScPharm(Hons) retweeted
🧠 New & available #OpenAccess! A randomized pilot trial found electroacupuncture showed promise for improving neuropsychiatric symptoms in AYA cancer survivors, with improvement increasing over time.
🔗: acsjournals.onlinelibrary.wi…
@alexchan928 @acharya_munjal @OncoAlert #ayacsm
Quinton Ng, PhD BScPharm(Hons) retweeted
Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in #Cancer Care.
ascopubs.org/doi/10.1200/JCO…
@ASCO @JCO_ASCO @JCOOP_ASCO
#PallOnc #SuppOnc #CancerCare
Quinton Ng, PhD BScPharm(Hons) retweeted
📢 Abstract titles for #ASCOQLTY26 are now live on @ASCO’s Digital Program!
Explore the latest research across Cost & Value, Health Care Access, Palliative Care, Patient Experience, Quality & Safety, Survivorship, and Technology & Innovation
asco.org/quality/search?filt…
Quinton Ng, PhD BScPharm(Hons) retweeted
New episode! #Blood editor Dr. James Griffin interviews Drs. George Goshua, Gerd Blobel, and Paul Kaminski on their latest papers. They cover cost-effectiveness of current #SCD treatments and potential therapeutic targets for fetal hemoglobinopathies
bloodpodcast.transistor.fm/e…
I practice AI detoxication to re-train myself.
"I realized writing is a process that not only transforms ideas into text, but also allows the writer to continuously question and refine those ideas. The AI never did this." #ScienceWorkingLife scim.ag/4zpKW3N
2
141
Quinton Ng, PhD BScPharm(Hons) retweeted
#MedNews: The latest #colorectal #cancer screening guidelines from the American Cancer Society include a blood test.
But #colonoscopies and stool tests are still the better options, the authors say.
Here’s why.
ja.ma/4qhMqIU
Quinton Ng, PhD BScPharm(Hons) retweeted
1/ My first paper in PGY2 residency landed in JAMA Oncology, and the truth is it was won before I ran a single analysis. It came down to how I chose the question. 8 Years later, I realized that very few trainees got taught about how to pick a first research idea. Lets try a bit
Quinton Ng, PhD BScPharm(Hons) retweeted
⭐July Editor's Choice: Applying #HealthEconomics and Outcomes Research Methods in #ValueBasedHealthcare Implementation: An #ISPOR Special Task Force Report
📖Free access: valueinhealthjournal.com/art…
#Healthcare #HEOR
Quinton Ng, PhD BScPharm(Hons) retweeted
On June 30, 2026, the NEJM retracted the clinical trial that got a drug approved by the FDA, triggering a $3.7B acquisition by Amgen.
The reason: the primary endpoint data was manipulated.
Here's how it happened, how it came to light, and who paid the price. 🧵







































